Overview Dividends

(AKE) Arkema - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0010313833

Adhesives, Acrylics, Resins, Fluorochemicals, Additives

Diversified Chemicals
Market Cap in USD: 4,645m

IPO / Inception:
Return 12m vs S&P 500: -34.2%

EPS (Earnings per Share)

EPS CAGR: -38.51%
EPS Trend: -72.2%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: -3.50%
Rev. Trend: -70.1%

Last SUE: 0.44
Qual. Beats: 0

Dividends

Dividend Yield	6.98%
Yield on Cost 5y	4.61%
Yield CAGR 5y	12.31%
Payout Consistency	97.0%
Payout Ratio	78.3%

Risk via 5d forecast
Volatility	27.6%
Value at Risk 5%th	43.3%
Relative Tail Risk	-4.51%

Reward TTM
Sharpe Ratio	-0.78
Alpha	-30.98
CAGR/Max DD	-0.29

Character TTM
Hurst Exponent	0.452
Beta	0.377
Beta Downside	0.528

Drawdowns 3y
Max DD	47.80%
Mean DD	17.93%
Median DD	14.95%

Description: AKE Arkema November 05, 2025

Arkema S.A. (NYSE: AKE) is a French-based specialty chemicals group that sells high-performance materials across Europe, North America and Asia. Its operations are organized into three segments: Adhesive Solutions (building-sector sealants, flooring adhesives, automotive and packaging polymers), Advanced Materials & Coating Solutions (acrylic resins, decorative paints, 3D-printing and electronics coatings) and Intermediates (fluorogases, acrylic monomers and other industrial chemicals).

Key recent metrics: FY 2023 revenue reached €9.2 billion, with an adjusted EBITDA margin of roughly 13 % and free cash flow conversion of 85 %. The company’s growth is being driven by rising demand for lightweight polymer solutions in electric-vehicle manufacturing, higher spending on sustainable construction materials in Europe, and expanding applications of fluoropolymers in water-treatment and semiconductor processes. A notable sector driver is the EU’s Green Deal, which is prompting stricter regulations on volatile organic compounds and encouraging the adoption of Arkema’s low-VOC coatings and recycling-focused polymer technologies.

For a deeper dive into Arkema’s valuation, competitive positioning and scenario analysis, check the ValueRay research hub.

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (143.0m TTM) > 0 and > 6% of Revenue (6% = 554.2m TTM)

FCFTA 0.02 (>2.0%) and ΔFCFTA -1.82pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 36.00% (prev 28.51%; Δ 7.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.07 (>3.0%) and CFO 980.0m > Net Income 143.0m (YES >=105%, WARN >=100%)

Net Debt (-1.95b) to EBITDA (1.00b) ratio: -1.95 <= 3.0 (WARN <= 3.5)

Current Ratio 3.07 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (76.1m) change vs 12m ago -7.79% (target <= -2.0% for YES)

Gross Margin 18.68% (prev 20.45%; Δ -1.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 63.80% (prev 64.77%; Δ -0.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.87 (EBITDA TTM 1.00b / Interest Expense TTM 111.0m) >= 6 (WARN >= 3)

Altman Z'' 3.44

(A) 0.23 = (Total Current Assets 4.93b - Total Current Liabilities 1.60b) / Total Assets 14.30b

(B) 0.31 = Retained Earnings (Balance) 4.48b / Total Assets 14.30b

(D) 0.76 = Book Value of Equity 5.24b / Total Liabilities 6.88b

Total Rating: 3.44 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 44.30

1. Piotroski 3.50pt

2. FCF Yield 3.32%

3. FCF Margin 2.64%

4. Debt/Equity 0.74

5. Debt/Ebitda -1.95

6. ROIC - WACC (= -2.04)%

7. RoE 1.95%

8. Rev. Trend -70.08%

9. EPS Trend -72.17%

What is the price of AKE shares?

As of December 22, 2025, the stock is trading at EUR 51.60 with a total of 553,554 shares traded.
Over the past week, the price has changed by -2.73%, over one month by +2.18%, over three months by -8.10% and over the past year by -22.65%.

Is AKE a buy, sell or hold?

Arkema has no consensus analysts rating.

What are the forecasts/targets for the AKE price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	64.1	24.1%
Analysts Target Price	-	-
ValueRay Target Price	49.8	-3.4%

AKE Fundamental Data Overview December 19, 2025

Market Cap USD = 4.65b (3.96b EUR * 1.1742 EUR.USD)
Market Cap EUR = 3.96b (3.96b EUR * 1.0 EUR.EUR)
P/E Trailing = 33.5256
P/E Forward = 13.1062
P/S = 0.4283
P/B = 0.5479
P/EG = 0.4673
Beta = 0.959
Revenue TTM = 9.24b EUR
EBIT TTM = 208.0m EUR
EBITDA TTM = 1.00b EUR
Long Term Debt = 3.37b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 142.0m EUR (from shortTermDebt, last quarter)
Debt = 5.36b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.95b EUR (from netDebt column, last quarter)
Enterprise Value = 7.36b EUR (3.96b + Debt 5.36b - CCE 1.95b)
Interest Coverage Ratio = 1.87 (Ebit TTM 208.0m / Interest Expense TTM 111.0m)
FCF Yield = 3.32% (FCF TTM 244.0m / Enterprise Value 7.36b)
FCF Margin = 2.64% (FCF TTM 244.0m / Revenue TTM 9.24b)
Net Margin = 1.55% (Net Income TTM 143.0m / Revenue TTM 9.24b)
Gross Margin = 18.68% ((Revenue TTM 9.24b - Cost of Revenue TTM 7.51b) / Revenue TTM)
Gross Margin QoQ = 18.56% (prev 19.00%)
Tobins Q-Ratio = 0.51 (Enterprise Value 7.36b / Total Assets 14.30b)
Interest Expense / Debt = 0.62% (Interest Expense 33.0m / Debt 5.36b)
Taxrate = 41.67% (25.0m / 60.0m)
NOPAT = 121.3m (EBIT 208.0m * (1 - 41.67%))
Current Ratio = 3.07 (Total Current Assets 4.93b / Total Current Liabilities 1.60b)
Debt / Equity = 0.74 (Debt 5.36b / totalStockholderEquity, last quarter 7.22b)
Debt / EBITDA = -1.95 (Net Debt -1.95b / EBITDA 1.00b)
Debt / FCF = -8.00 (Net Debt -1.95b / FCF TTM 244.0m)
Total Stockholder Equity = 7.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.00% (Net Income 143.0m / Total Assets 14.30b)
RoE = 1.95% (Net Income TTM 143.0m / Total Stockholder Equity 7.34b)
RoCE = 1.94% (EBIT 208.0m / Capital Employed (Equity 7.34b + L.T.Debt 3.37b))
RoIC = 1.31% (NOPAT 121.3m / Invested Capital 9.24b)
WACC = 3.35% (E(3.96b)/V(9.31b) * Re(7.40%) + D(5.36b)/V(9.31b) * Rd(0.62%) * (1-Tc(0.42)))
Discount Rate = 7.40% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.22%
[DCF Debug] Terminal Value 75.68% ; FCFE base≈353.2m ; Y1≈300.3m ; Y5≈230.4m
Fair Price DCF = 55.73 (DCF Value 4.22b / Shares Outstanding 75.6m; 5y FCF grow -18.17% → 3.0% )
EPS Correlation: -72.17 | EPS CAGR: -38.51% | SUE: -4.0 | # QB: 0
Revenue Correlation: -70.08 | Revenue CAGR: -3.50% | SUE: 0.44 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.27 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=5.64 | Chg30d=-0.132 | Revisions Net=-6 | Growth EPS=+16.4% | Growth Revenue=+1.5%

Additional Sources for AKE Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle